Literature DB >> 12796672

Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.

Michael A Diefenbach1, Natalie Hamrick, Robert Uzzo, Alan Pollack, Eric Horwitz, Richard Greenberg, Paul F Engstrom.   

Abstract

PURPOSE: We examined complementary and alternative medicine (CAM) use among men who received standard therapy for localized prostate cancer.
MATERIALS AND METHODS: A total of 417 men completed a questionnaire 6 months after their treatment decision assessing clinical and psychosocial variables and use of 41 available CAM therapies grouped into the 2 general categories of herbal/dietary and nonherbal (i.e. mind-body, bioelectromagnetic, traditional/folk medicine, pharmacological/biological).
RESULTS: The prostate cancer diagnosis prompted 19% of our sample to start using some form of CAM for prostate health, and 67% of men reported having used some form of CAM for prostate health before being diagnosed. Initiation of CAM was associated with being a member of an ethnic minority group and a higher level of education. Initiation of nonherbal CAM was associated with being married, while use of herbal CAM therapies was significantly associated with choosing observation. Herbal use before diagnosis was associated with being white, higher level of education and being single. Prostate specific antigen at diagnosis, Gleason score, quality of life, participant perceptions of seriousness of prostate cancer or self-reported worry about prostate cancer were not related to initiation or prior use. Of those men reporting current use almost 50% did not inform their treating physician of using CAM therapies.
CONCLUSIONS: Initiation of CAM therapies as a result of a prostate cancer diagnosis was fairly low, although two-thirds of men had used it before diagnosis. Half of the patients did not inform their physicians about such use and physicians should continue to probe patients about CAM use.

Entities:  

Mesh:

Year:  2003        PMID: 12796672     DOI: 10.1097/01.ju.0000070963.12496.cc

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

2.  Use of complementary and alternative medicine among men with prostate cancer in a rural setting.

Authors:  Susan Butler; Ashli Owen-Smith; Colleen DiIorio; Michael Goodman; Jonathan Liff; Kyle Steenland
Journal:  J Community Health       Date:  2011-12

Review 3.  Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Authors:  Raquel Gerson-Cwilich; Alberto Serrano-Olvera; Alberto Villalobos-Prieto
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

Review 4.  Changes in fat-soluble vitamin levels after gastrectomy for gastric cancer.

Authors:  Yasushi Rino; Takashi Oshima; Takaki Yoshikawa
Journal:  Surg Today       Date:  2016-05-25       Impact factor: 2.549

5.  Complementary and alternative medicine use among newly diagnosed prostate cancer patients.

Authors:  Cara L McDermott; David K Blough; Catherine R Fedorenko; Neeraj K Arora; Steven B Zeliadt; Megan E Fairweather; Ingrid Oakley-Girvan; Stephen K Van Den Eeden; Scott D Ramsey
Journal:  Support Care Cancer       Date:  2010-12-01       Impact factor: 3.603

6.  Men's health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer.

Authors:  Nicholas G Zaorsky; Thomas M Churilla; Karen Ruth; Shelly B Hayes; Mark L Sobczak; Mark A Hallman; Marc C Smaldone; David Yt Chen; Eric M Horwitz
Journal:  Am J Clin Nutr       Date:  2016-10-26       Impact factor: 7.045

7.  Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia.

Authors:  Jeannette Y Lee; Harris E Foster; Kevin T McVary; Sreelatha Meleth; Karen Stavris; Joe Downey; John W Kusek
Journal:  J Altern Complement Med       Date:  2011-05-09       Impact factor: 2.579

8.  Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution.

Authors:  Koji Yoshimura; Nobufumi Ueda; Kentaro Ichioka; Yoshiyuki Matsui; Akito Terai; Yoichi Arai
Journal:  Support Care Cancer       Date:  2005-06-10       Impact factor: 3.603

9.  Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors.

Authors:  Randy A Jones; Ann Gill Taylor; Cheryl Bourguignon; Richard Steeves; Gertrude Fraser; Marguerite Lippert; Dan Theodorescu; Holly Mathews; Kerry Laing Kilbridge
Journal:  Oncol Nurs Forum       Date:  2007-03       Impact factor: 2.172

10.  Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.

Authors:  Thomas M Habermann; Carrie A Thompson; Betsy R LaPlant; Brent A Bauer; Carol A Janney; Matthew M Clark; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Susan M Geyer; James R Cerhan
Journal:  Am J Hematol       Date:  2009-12       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.